Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004902348 | SCV005561811 | uncertain significance | not specified | 2024-07-17 | criteria provided, single submitter | clinical testing | The c.175A>G (p.K59E) alteration is located in exon 4 (coding exon 2) of the ADAT1 gene. This alteration results from a A to G substitution at nucleotide position 175, causing the lysine (K) at amino acid position 59 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |